SEC Form SC 13G/A filed by OrthoPediatrics Corp. (Amendment)
$KIDS
Medical/Dental Instruments
Health Care
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/10/2025 | $24.00 | Buy | Canaccord Genuity |
| 4/7/2025 | $37.00 | Buy | Lake Street |
| 1/25/2024 | $39.00 → $31.00 | Buy → Hold | Truist |
| 3/3/2022 | $83.00 → $65.00 | Buy | Needham |
| 12/22/2021 | $75.00 → $68.00 | Buy | BTIG |
| 12/21/2021 | $78.00 → $75.00 | Buy | Truist Securities |
| 8/6/2021 | $70.00 → $77.00 | Market Outperform | JMP Securities |
4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
3 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
WARSAW, Ind., Nov. 13, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing ("OPSB") portfolio with two new products launches, the PediHip™ Rigid Brace and PediHip™ Modular Abduction Systems. The company now has 31 systems within its OPSB division. Developed in collaboration with globally recognized pediatric hip experts, the PediHip™ Rigid Brace and PediHip™ Modular Abduction System are intended for the treatment of Developmental Dysplasia of the Hip (DDH) and post-operative stabilization in ped
WARSAW, Ind., Nov. 04, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it will participate in three upcoming investor conferences. Event: Stifel 2025 Healthcare Conference Format: Fireside Chat Date: Thursday, November 13, 2025Time: 1:20 pm ET Event: Jeffries Global Healthcare Conference in LondonFormat: Presentation Date: Tuesday, November 18, 2025Time: 12:00 pm ET Event: Piper 37th Annual Healthcare Conference Format: Fireside Chat Date: Thursday, December 4,
WARSAW, Ind., Oct. 28, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the third quarter ended September 30, 2025. Third Quarter 2025 and Recent Business Highlights Helped over 37,000 children in the third quarter of 2025 and approximately 1.3 million children to dateGenerated new record high total revenue of $61.2 million for the third quarter of 2025, up 12% from $54.6 million in third quarter 2024; domestic revenue increased 14% and international revenue increased 6% in the quarterGenerated total revenue exclu
Canaccord Genuity initiated coverage of OrthoPediatrics with a rating of Buy and set a new price target of $24.00
Lake Street initiated coverage of OrthoPediatrics with a rating of Buy and set a new price target of $37.00
Truist downgraded OrthoPediatrics from Buy to Hold and set a new price target of $31.00 from $39.00 previously
SCHEDULE 13G/A - ORTHOPEDIATRICS CORP (0001425450) (Subject)
SCHEDULE 13G - ORTHOPEDIATRICS CORP (0001425450) (Subject)
10-Q - ORTHOPEDIATRICS CORP (0001425450) (Filer)
4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
WARSAW, Ind., Aug. 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the appointment of Kelly Fischer to its Board of Directors effective as of August 8, 2025. The appointment was made concurrent with the announcement of the retirement of Terry Schlotterback from the OrthoPediatrics Board of Directors, effective as of August 8, 2025. "We're excited to welcome Kelly Fischer to the OrthoPediatrics Board of Directors. Her proven expertise in financial leadership at Cook Medical will be a significant asset as we execute our strategy and expand our
WARSAW, Ind., March 17, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its partnership with the Crossroads Pediatric Device Consortium (CPDC). This collaboration aligns with the Company's cause of improving the lives of children by supporting the development and commercialization of innovative pediatric medical devices. The Crossroads Pediatric Device Consortium is a multi-institutional initiative focused on accelerating the development, approval, and availability of medical devices designed specifically for pediatric patients. Founding member
WARSAW, Ind., Oct. 12, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, has announced a strategic partnership with Children's National Hospital in Washington, DC under the "Alliance for Pediatric Device Innovation" (APDI), to advice the development and commercialization of medical devices designed for children. Along with Children's National, APDI consortium members include Johns Hopkins University, CIMIT at Mass General Brigham, Tufts Medical Center and Medstar Health Research Institute. The Company will serve as APDI's strategic advisor and role model for devic
WARSAW, Ind., Oct. 28, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the third quarter ended September 30, 2025. Third Quarter 2025 and Recent Business Highlights Helped over 37,000 children in the third quarter of 2025 and approximately 1.3 million children to dateGenerated new record high total revenue of $61.2 million for the third quarter of 2025, up 12% from $54.6 million in third quarter 2024; domestic revenue increased 14% and international revenue increased 6% in the quarterGenerated total revenue exclu
WARSAW, Ind., Oct. 15, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 2025 financial results on October 28, 2025 after the market closes. OrthoPediatrics will host a conference call on Tuesday, October 28, 2025 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available
WARSAW, Ind., Oct. 09, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced preliminary unaudited financial highlights for the third quarter ended September 30, 2025, and revised 2025 financial guidance. Preliminary Third Quarter 2025 Results Helped over 37,100 children in the third quarter 2025, the Company has now helped approximately 1.3 million children since inceptionGenerated preliminary unaudited third quarter 2025 net revenue of approximately $61.2 million, representing growth of 12% compared to $54.6 million in the third quarter of 2024. P
SC 13G/A - ORTHOPEDIATRICS CORP (0001425450) (Subject)
SC 13G/A - ORTHOPEDIATRICS CORP (0001425450) (Subject)
SC 13G/A - ORTHOPEDIATRICS CORP (0001425450) (Subject)